Kathryn R. Starr

Characterization of a CNS penetrant, selective M₁muscarinic receptor agonist, 77‐LH‐28‐1

Christopher J. Langmead, Nigel Austin, Clive L. Branch et al. · British Journal of Pharmacology · 2008 · 131 citations · Full text

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone

Zoë A. Hughes, Kathryn R. Starr, Christopher J. Langmead et al. · European Journal of Pharmacology · 2005 · 121 citations

Psychiatry, Functional Selectivity, Medicine +9

Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX 1 ) receptors, with downstream 5-HT 2C receptor involvement

Mark Duxon, Jennifer L. Stretton, Kathryn R. Starr et al. · Psychopharmacology · 2001 · 93 citations

Behavioral Neuroscience, Medicine, Physiology +8

Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia

Melanie J. Robbins, Kathryn R. Starr, Andy Honey et al. · Brain Research · 2007 · 60 citations

Psychiatry, Psychotic Disorder, Medicine +10

3,4-Dihydro-2H-benzoxazinones are 5-HT1A receptor antagonists with potent 5-HT reuptake inhibitory activity

Peter J. Atkinson, Steven M. Bromidge, Mark Duxon et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 55 citations · Full text

Molecular Pharmacology, Biochemistry, Functional Selectivity +8